⌘K

Login Start Free

Home/Filings/4/0001493152-23-005058

4//SEC Filing

Martell Robert 4

Accession 0001493152-23-005058

CIK 0001857044other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:58 PM ET

Size

5.3 KB

Accession

0001493152-23-005058

Insider Transaction Report

Form 4

Period: 2023-02-13

Indaptus Therapeutics, Inc.INDP

Director

Transactions

Award
Stock Option (Right to Buy)
2023-02-13+20,000→ 20,000 total
Exercise: $1.71Exp: 2033-02-13→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable on February 13, 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1

filerCIK 0001529922

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 5:58 PM ET
Size: 5.3 KB

View on SEC.gov